These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21803632)

  • 1. Genetics of Dupuytren's disease.
    Michou L; Lermusiaux JL; Teyssedou JP; Bardin T; Beaudreuil J; Petit-Teixeira E
    Joint Bone Spine; 2012 Jan; 79(1):7-12. PubMed ID: 21803632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide analysis using exon arrays demonstrates an important role for expression of extra-cellular matrix, fibrotic control and tissue remodelling genes in Dupuytren's disease.
    Forrester HB; Temple-Smith P; Ham S; de Kretser D; Southwick G; Sprung CN
    PLoS One; 2013; 8(3):e59056. PubMed ID: 23554969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive association of HLA-DRB1*15 with Dupuytren's disease in Caucasians.
    Brown JJ; Ollier W; Thomson W; Bayat A
    Tissue Antigens; 2008 Aug; 72(2):166-70. PubMed ID: 18721277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of an autosomal dominant gene for Dupuytren's contracture to chromosome 16q in a Swedish family.
    Hu FZ; Nystrom A; Ahmed A; Palmquist M; Dopico R; Mossberg I; Gladitz J; Rayner M; Post JC; Ehrlich GD; Preston RA
    Clin Genet; 2005 Nov; 68(5):424-9. PubMed ID: 16207209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dupuytren's disease susceptibility gene, EPDR1, is involved in myofibroblast contractility.
    Staats KA; Wu T; Gan BS; O'Gorman DB; Ophoff RA
    J Dermatol Sci; 2016 Aug; 83(2):131-7. PubMed ID: 27245865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a novel gene, MafB, in Dupuytren's disease.
    Lee LC; Zhang AY; Chong AK; Pham H; Longaker MT; Chang J
    J Hand Surg Am; 2006 Feb; 31(2):211-8. PubMed ID: 16473681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA copy number variations at chromosome 7p14.1 and chromosome 14q11.2 are associated with dupuytren's disease: potential role for MMP and Wnt signaling pathway.
    Shih B; Tassabehji M; Watson JS; Bayat A
    Plast Reconstr Surg; 2012 Apr; 129(4):921-932. PubMed ID: 22183494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt expression is not correlated with beta-catenin dysregulation in Dupuytren's Disease.
    O'Gorman DB; Wu Y; Seney S; Zhu RD; Gan BS
    J Negat Results Biomed; 2006 Aug; 5():13. PubMed ID: 16942611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.
    Qian A; Meals RA; Rajfer J; Gonzalez-Cadavid NF
    Urology; 2004 Aug; 64(2):399-404. PubMed ID: 15302515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic aspect of Dupuytren's diseases].
    Bobiński R; Olczyk K; Wisowski G; Janusz W
    Wiad Lek; 2004; 57(1-2):59-62. PubMed ID: 15181751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular phenotypic descriptors of Dupuytren's disease defined using informatics analysis of the transcriptome.
    Rehman S; Salway F; Stanley JK; Ollier WE; Day P; Bayat A
    J Hand Surg Am; 2008 Mar; 33(3):359-72. PubMed ID: 18343292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel mitochondrial mutation in Dupuytren's disease using multiplex DHPLC.
    Bayat A; Walter J; Lambe H; Watson JS; Stanley JK; Marino M; Ferguson MW; Ollier WE
    Plast Reconstr Surg; 2005 Jan; 115(1):134-41. PubMed ID: 15622243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology of Dupuytren's disease].
    Hahn P
    Orthopade; 2017 Apr; 46(4):298-302. PubMed ID: 28180912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of myoglobin and ROR2 protein in Dupuytren's disease.
    Forsman M; Pääkkönen V; Tjäderhane L; Vuoristo J; Kallioinen L; Salo T; Kallioinen M; Ryhänen J
    J Surg Res; 2008 May; 146(2):271-5. PubMed ID: 17996904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole genome and global expression profiling of Dupuytren's disease: systematic review of current findings and future perspectives.
    Shih B; Watson S; Bayat A
    Ann Rheum Dis; 2012 Sep; 71(9):1440-7. PubMed ID: 22772327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of genetic susceptibility in Dupuytren's disease.
    Becker K; Tinschert S; Lienert A; Bleuler PE; Staub F; Meinel A; Rößler J; Wach W; Hoffmann R; Kühnel F; Damert HG; Nick HE; Spicher R; Lenze W; Langer M; Nürnberg P; Hennies HC
    Clin Genet; 2015 May; 87(5):483-7. PubMed ID: 24749973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of HLA-DRB1*01 with Dupuytren's disease.
    Jónsson T; Gudmundsson KG; Bjarnadóttir K; Hjálmarsdótti IB; Gudmundsson S; Arngrímsson R
    Scand J Rheumatol; 2013; 42(1):45-7. PubMed ID: 22991974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren's disease.
    Riester SM; Arsoy D; Camilleri ET; Dudakovic A; Paradise CR; Evans JM; Torres-Mora J; Rizzo M; Kloen P; Julio MK; van Wijnen AJ; Kakar S
    BMC Med Genomics; 2015 Oct; 8():59. PubMed ID: 26446724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease.
    Johnston P; Chojnowski AJ; Davidson RK; Riley GP; Donell ST; Clark IM
    J Hand Surg Am; 2007 Mar; 32(3):343-51. PubMed ID: 17336841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association scan of Dupuytren's disease.
    Ojwang JO; Adrianto I; Gray-McGuire C; Nath SK; Sun C; Kaufman KM; Harley JB; Rayan GM
    J Hand Surg Am; 2010 Dec; 35(12):2039-45. PubMed ID: 20971583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.